These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Angiotensin converting enzyme inhibitors in arterial hypertension and cardiac failure. The question of the dose].
    Author: González-Juanatey JR.
    Journal: Med Clin (Barc); 2000; 114 Suppl 2():24-7. PubMed ID: 10916802.
    Abstract:
    The clinical use of the angiotensin enzyme converter inhibitors (AECI) has represented one of the main advances in medicine in the last quarter of a century. Assuming the pathogenic pluripotentialness of cardiovascular diseases (arterial hypertension, atherosclerosis, cardiac failure etc.), from the currently available experimental and clinical evidence of these compounds, it may be said that the mechanisms of action of the AECI make them to be the first pharmacologic group in cardiovascular medicine to have true pluripotentialness.
    [Abstract] [Full Text] [Related] [New Search]